Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Carlsmed (CARL) EBITDA Margin (2024 - 2025)

Carlsmed's EBITDA Margin history spans 2 years, with the latest figure at 56.8% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 663.0% year-over-year to 56.8%; the TTM value through Dec 2025 reached 57.56%, changed N/A, while the annual FY2025 figure was 58.67%, 3063.0% up from the prior year.
  • EBITDA Margin reached 56.8% in Q4 2025 per CARL's latest filing, up from 65.21% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 50.17% in Q4 2024 to a low of 118.56% in Q3 2024.